From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy-Reference-Cited by-同舟云学术

From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy

Published:2019-07-02 Issue:1 Volume:20 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Bianco F.,Ricci F.,Catozzi C.,Murgia X.,Schlun M.,Bucholski A.,Hetzer U.,Bonelli S.,Lombardini M.,Pasini E.,Nutini M.,Pertile M.,Minocchieri S.,Simonato M.,Rosa B.,Pieraccini G.,Moneti G.,Lorenzini L.,Catinella S.,Villetti G.,Civelli M.,Pioselli B.,Cogo P.,Carnielli V.,Dani C.,Salomone F.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-019-1096-9.pdf

Reference62 articles.

1. Gizzi C, Montecchia F, Panetta V, Castellano C, Mariani C, Campelli M, et al. Is synchronised NIPPV more effective than NIPPV and NCPAP in treating apnoea of prematurity (AOP)? A randomised cross-over trial. Arch Dis Child - Fetal Neonatal Ed. 2015;100:F17 LP–F23.

2. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet J-M, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358:700–8.

3. Vento M. Tailoring oxygen needs of extremely low birth weight infants in the delivery room. Neonatology. 2011:342–8.

4. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–34.

5. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3:CD000510.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part II: In vivo Efficacy Testing in a Rabbit Surfactant Washout Model;Pharmaceutical Research;2024-09-05

2. Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization;Pharmaceutical Research;2024-08

3. Surfactant therapy using vibrating-mesh nebulizers in adults with COVID-19-induced ARDS: A case series;SAGE Open Medical Case Reports;2024-01

4. Positive end‐expiratory pressure and surfactant administration mode influence function in ex‐vivo premature sheep lungs;Acta Paediatrica;2023-12-27

5. Predictors of successful treatment of respiratory distress with aerosolized calfactant;Journal of Perinatology;2023-07-11